Table 1.
1 | 2 | 3 | |
---|---|---|---|
Sex | M | F | F |
Age | 37 | 74 | 48 |
Smoking Status | No | No | No |
Exposure | No | No | No |
Allergies | Acarus, olive, grasses | No | No |
Age onset asthma | 37 | 74 | 33 |
FEV1 (% pred) | 84 | 120 | 86 |
DLCO (% pred) | 74 | 62 | 68 |
Blood tests | Not relevant | IgE: 211 | Eosinophils: 0,80 × 103/mmc (11,5%) IgE: 442 |
Asthma therapy | Beclomethasone/Formoterol 200/6 bid | Beclomethasone/Formoterol 100/6 2 puff bid | Os: Prednisone 5 mg qd; Fluticasone/Vilanterol 184/22 qd |
CT scan abnormalities | Peribronchiolar ground glass attenuation in the RUL, in the lingula and in both the posterior segments of the lower lobes. A thickening of the bronchial walls | Peribronchiolar ground glass opacities in the RUL, RLL, alveolar consolidations in the RLL and mediastinal lymphoadenopathies | Centrilobular micronodules and bronchiectasis in the medium lobe, in the right superior and inferior lobes |
RUL right upper lobe, RLL right lower lobe, LLL left lower lobe